Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_pagePreview
Managing Patient Enrollment in Acromegaly Rare Disease Studies

In rare disease, every patient matters and it is important for CRO and sponsor medical staff to effectively monitor and...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Brexit is here - Is your clinical trial-ready?

The United Kingdom officially withdrew from the European Union (EU) on Jan 31, 2020. They have until Dec 31, 2020 to complete...


(3 minute read)

Tags: Pharm-Olam Insights, Global Coverage

The Benefits of Conducting Clinical Research in Russia

Pharm-Olam, as a global CRO, has over 20 years' experience conducting clinical trials in Central and Eastern Europe (CEE). In...


(4 minute read)

Tags: Pharm-Olam Insights, Global Coverage

Current Trends in Allergy Immunotherapy

Pharm-Olam is an allergy focused CRO and have worked on over 35 allergy clinical trials. In this article, we explore the area...


(8 minute read)

Tags: Pharm-Olam Insights, Allergy & Immunology

Medical Data Reviewer: Pharm-Olam’s Secret to Study Success

Effective Data management plays a critical role in the conduct of clinical trials. Clinical research requires quality data...


(1 minute read)

Tags: Pharm-Olam Insights, Data Management

Challenges Working with Terminally-Ill Patients in an International Rare Disease Study

Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger

Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...


(3 minute read)

Tags: Rare & Orphan Disease

Complexities of Combining Adults into Protocol with Pediatrics and Adolescents

Conducting Phase I studies is always complex. At this stage in clinical research, you are examining the tolerability of the...


(1 minute read)

Tags: Pharm-Olam Insights, Allergy & Immunology

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover